Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit [4]

Wirongrong Chierakul; Siriluck Anunnatsiri; Wipada Chaowagul; Sharon J. Peacock; Ploenchan Chetchotisakd; Nicholas P. Day

doi:10.1086/520011

Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit [4]

Wirongrong Chierakul
, Siriluck Anunnatsiri
, Wipada Chaowagul
, Sharon J. Peacock
, Ploenchan Chetchotisakd
, Nicholas P. Day

Department of Clinical Tropical Medicine

Mahidol University
Faculty of Medicine, Khon Kaen University
Sapasittiprasong Hospital
Nuffield Department of Medicine

Research output: Contribution to journal › Letter › peer-review

21 Citations (Scopus)

Original language	English
Pages (from-to)	521-523
Number of pages	3
Journal	Clinical Infectious Diseases
Volume	45
Issue number	4
DOIs	https://doi.org/10.1086/520011
Publication status	Published - 15 Aug 2007

Access to Document

10.1086/520011

Cite this

@article{bdb60d37af8541cc882ef5cee2f838c0,

title = "Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit [4]",

author = "Wirongrong Chierakul and Siriluck Anunnatsiri and Wipada Chaowagul and Peacock, \{Sharon J.\} and Ploenchan Chetchotisakd and Day, \{Nicholas P.\}",

year = "2007",

month = aug,

day = "15",

doi = "10.1086/520011",

language = "English",

volume = "45",

pages = "521--523",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit [4]

AU - Chierakul, Wirongrong

AU - Anunnatsiri, Siriluck

AU - Chaowagul, Wipada

AU - Peacock, Sharon J.

AU - Chetchotisakd, Ploenchan

AU - Day, Nicholas P.

PY - 2007/8/15

Y1 - 2007/8/15

UR - https://www.scopus.com/pages/publications/34547647816

U2 - 10.1086/520011

DO - 10.1086/520011

M3 - Letter

C2 - 17638209

AN - SCOPUS:34547647816

SN - 1058-4838

VL - 45

SP - 521

EP - 523

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 4

ER -

Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit [4]

Access to Document

Other files and links

Cite this